- Home
- MOLN vs SJT Comparison
MOLN vs SJT Comparison
Compare MOLN & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- SJT
- Stock Information
- Founded
- MOLN 2004
- SJT 1980
- Country
- MOLN Switzerland
- SJT United States
- Employees
- MOLN N/A
- SJT N/A
- Industry
- MOLN
- SJT Oil & Gas Production
- Sector
- MOLN
- SJT Energy
- Exchange
- MOLN Nasdaq
- SJT Nasdaq
- Market Cap
- MOLN 192.4M
- SJT 212.1M
- IPO Year
- MOLN 2021
- SJT N/A
- Fundamental
- Price
- MOLN $5.04
- SJT $4.00
- Analyst Decision
- MOLN
- SJT
- Analyst Count
- MOLN 0
- SJT 0
- Target Price
- MOLN N/A
- SJT N/A
- AVG Volume (30 Days)
- MOLN 5.7K
- SJT 230.2K
- Earning Date
- MOLN 03-13-2025
- SJT 11-14-2024
- Dividend Yield
- MOLN N/A
- SJT 2.33%
- EPS Growth
- MOLN N/A
- SJT N/A
- EPS
- MOLN N/A
- SJT 0.19
- Revenue
- MOLN $7,105,397.00
- SJT $11,031,594.00
- Revenue This Year
- MOLN N/A
- SJT N/A
- Revenue Next Year
- MOLN $29.41
- SJT N/A
- P/E Ratio
- MOLN N/A
- SJT $21.16
- Revenue Growth
- MOLN N/A
- SJT N/A
- 52 Week Low
- MOLN $3.32
- SJT $3.21
- 52 Week High
- MOLN $12.70
- SJT $5.81
- Technical
- Relative Strength Index (RSI)
- MOLN 41.97
- SJT 41.94
- Support Level
- MOLN $5.22
- SJT $3.96
- Resistance Level
- MOLN $5.35
- SJT $4.30
- Average True Range (ATR)
- MOLN 0.12
- SJT 0.16
- MACD
- MOLN -0.03
- SJT -0.05
- Stochastic Oscillator
- MOLN 0.00
- SJT 5.42
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.